DelistingMay 20, 2026, 04:13 PM
Aimei Health receives Nasdaq delisting notice for delayed 10-Q
AI Summary
Aimei Health Technology Co., Ltd. received a notice from Nasdaq on May 19, 2026, indicating non-compliance with listing rules due to the delayed filing of its Quarterly Report on Form 10-Q for the quarter ended March 31, 2026. The report was due on May 15, 2026. While there is no immediate impact on the company's stock listing, failure to regain compliance could lead to delisting. The company has 60 days to file the report or submit a compliance plan and is diligently working to complete the filing.
Key Highlights
- Aimei Health received a Nasdaq notice on May 19, 2026, for delayed Q1 2026 Form 10-Q.
- Company is non-compliant with Nasdaq Listing Rule 5250(c)(1) for timely financial reporting.
- The Quarterly Report for March 31, 2026, was due on May 15, 2026.
- The notice has no immediate effect on the company's stock listing or trading.
- Aimei Health has 60 calendar days to file the report or submit a compliance plan.
- If a plan is accepted, the company could be granted up to 180 calendar days from May 15, 2026.
- The company is working diligently to file the report and expects to regain compliance.
Price Impact
More from AFJK